
GZ389988
CAS No. 1788906-96-6
GZ389988( GZ-389988 | GZ 389988 )
Catalog No. M12693 CAS No. 1788906-96-6
GZ389988 (GZ-389988) is a novel potent, selective, locally delivered TrkA inhibitor for the treatment osteoarthritis; shows similar IC50 values for TrkA, TrkB and TrkC, and the growth factor receptor cFMS (CSF1R).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGZ389988
-
NoteResearch use only, not for human use.
-
Brief DescriptionGZ389988 (GZ-389988) is a novel potent, selective, locally delivered TrkA inhibitor for the treatment osteoarthritis; shows similar IC50 values for TrkA, TrkB and TrkC, and the growth factor receptor cFMS (CSF1R).
-
DescriptionGZ389988 (GZ-389988) is a novel potent, selective, locally delivered TrkA inhibitor for the treatment osteoarthritis; shows similar IC50 values for TrkA, TrkB and TrkC, and the growth factor receptor cFMS (CSF1R), GZ389988 is highly selective against a wide panel of other kinases; GZ389988 can significantly reduces local joint pain, without effect on ipsilateral joint pain; GZ389988 also is efficacious in the PGPS arthritis model, demonstrating a significant improvement of gait analysis scores following painful disease reactivation flares.Other Indication Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsGZ-389988 | GZ 389988
-
PathwayTyrosine Kinase
-
TargetTrk Receptor
-
RecptorTrk Receptor
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number1788906-96-6
-
Formula Weight470.533
-
Molecular FormulaC26H26N6O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC1=NC2=CC(C3=CN(C)N=C3)=CN=C2N1CC4=CC=C(OCC5=CC=C(OC)C=C5)C(OC)=C4
-
Chemical Name3-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)-6-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-2-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
GNF-8625 monopyridin...
GNF-8625 monopyridin-N-piperazine hydrochloride is a tropomyosin receptor kinase (TRK) inhibitor.
-
CH7057288
CH7057288 is an effective and selective TRK inhibitor with an IC50 value of 1.1 nM 7.8 nM and 5.1 nM for TRKA TRKB and TRKC respectively.
-
CG 428
CG 428 is a potent tropomyosin receptor Kinase (TRK) Degrader (uSMITETM) with a DC50 of 0.36 nM. CG 428 comprises an analog of the pan-TRK inhibitor GNF-8625 joined by a linker to the cereblon E3 ligase ligand pomalidomide.